Clinical data suggests that approximately 375 out of 1000 patients achieve 10% weight reduction over two years with GLP-1 medications
You wont suddenly be able to eat an enormous meal of rich foods without feeling side effects
Sibal R, Balamurugan G, Langley J, Graham Y, Mahawar K, Macronutrient
Diabetologia 38(6):720725 Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S et al (2009) Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
Increasing competition would drive down prices and expand access to GLP-1 products for everyone, particularly those most in need